Latest Breaking News On - Treace medical concepts company profile - Page 1 : comparemela.com

Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) Director Richard W. Mott acquired 12,100 shares of the company’s stock in a transaction on Wednesday, May 22nd. The shares were acquired at an average cost of $4.99 per share, for a total transaction of $60,379.00. Following the completion of the acquisition, the director now owns […]

United statesStifel nicolausZurcher kantonalbank zurich cantonalbankRichardw mottTreace medical concepts incTreace medical concepts company profileMorgan stanleyQuest partnersRiverpark advisorsNewbridge financial services group incAssociates corpSecurities exchange commissionTreace medical conceptsGet free reportDirector richardExchange commission